Reference Source

Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.

65219-462-10 · Dextrose Monohydrate 5% Injection · Fresenius Kabi USA, LLC

What is the package ndc for 65219-462-10 · Dextrose Monohydrate 5% Injection · Fresenius Kabi USA, LLC?

For 65219-462-10 · Dextrose Monohydrate 5% Injection · Fresenius Kabi USA, LLC, package ndc is 65219-462-10; generic name is Dextrose Monohydrate 5% Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

"initial_posting_date": "02/14/2022", "package_ndc": "65219-462-10", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-386-1300", "availability": "Unavailable", "related_info": "Next release September 2026. Check wholesalers for inventory."

api.fda.gov, retrieved 2026-09-01

Package NDC
65219-462-10 verified
Generic name
Dextrose Monohydrate 5% Injection verified
Manufacturer
Fresenius Kabi USA, LLC verified
Status
Current verified
Availability now
Unavailable verified
FDA note
Next release September 2026. Check wholesalers for inventory. verified
Initial posting date
02/14/2022 verified
Last update date
08/25/2026 verified
Days in shortage
1660 our reading
Reason for shortage
Demand increase for the drug verified
Dosage form
Injection verified
Therapeutic category
Endocrinology/Metabolism verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/25/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Other", "Pediatric" ], "dosage_form": "Injection", "presentation": "Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.